TipRanks
BacTech Environmental (TSE:BAC)
:BAC
Want to see TSE:BAC full AI Analyst Report?

BacTech Environmental (BAC) AI Stock Analysis

21 Followers

Top Page

TSE:BAC

BacTech Environmental

(BAC)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - Gpt-5.6Sol)
Rating:43Neutral
Price Target:
C$0.04
▲(7.50% Upside)
Action:Reiterated
Date:10/02/26
The score is driven primarily by weak financial performance: no revenue, ongoing losses, negative operating/free cash flow, and negative equity (despite improved leverage). Technical indicators are broadly neutral with slightly bearish momentum, providing limited support. Valuation is also constrained by a negative P/E and no dividend yield data.
Positive Factors
Dual-purpose environmental technology
The company’s bioleaching platform addresses two durable needs: reducing environmental liabilities from toxic materials and potentially recovering valuable metals. That combination could support customer value beyond disposal alone and create a differentiated basis for commercialization if the processes scale successfully.
Negative Factors
No commercial revenue
The absence of reported revenue indicates that the company has not yet established a commercial top-line base across the periods provided. This limits evidence of customer adoption, makes operating costs harder to support internally, and leaves future growth dependent on successful commercialization.
Read all positive and negative factors
Positive Factors
Negative Factors
Dual-purpose environmental technology
The company’s bioleaching platform addresses two durable needs: reducing environmental liabilities from toxic materials and potentially recovering valuable metals. That combination could support customer value beyond disposal alone and create a differentiated basis for commercialization if the processes scale successfully.
Read all positive factors

BacTech Environmental (BAC) vs. iShares MSCI Canada ETF (EWC)

BacTech Environmental Business Overview & Revenue Model

Company Description
BacTech Environmental Corporation operates as a specialized firm in environmental technology. Its core business involves developing and commercializing BACOX, an exclusive bioleaching method. This innovative technology harnesses bacteria to both r...
How the Company Makes Money
Publicly available information is insufficient to describe BacTech Environmental’s current, specific revenue model and material revenue streams with high confidence. null...

BacTech Environmental Financial Statement Overview

Summary
Financial quality is weak: the company reports no revenue across periods provided, with persistent negative EBIT/EBITDA and recurring net losses. Cash flow is consistently negative (including TTM operating cash flow around -1.4M) with free cash flow deterioration in 2025/TTM, implying ongoing funding needs. Balance sheet flexibility is constrained by negative stockholders’ equity in every period (including TTM), despite a positive trend of materially lower debt in the most recent period.
Income Statement
8
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
10
Very Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Dec 2021
Income Statement
Total Revenue0.000.000.000.000.000.00
Gross Profit0.000.00-100.00K-161.00K-954.00K-208.15K
EBITDA-1.14M-1.63M-505.73K-3.00-3.20M-1.36M
Net Income-422.46K-1.80M-836.00K-1.92M-3.37M-1.60M
Balance Sheet
Total Assets2.06M1.49M1.87M1.45M1.14M234.97K
Cash, Cash Equivalents and Short-Term Investments949.06K391.93K760.36K73.20K10.15K64.28K
Total Debt160.00K160.00K1.44M1.44M1.03M160.00K
Total Liabilities3.11M3.16M4.80M3.66M3.09M1.65M
Stockholders Equity-1.05M-1.67M-2.93M-2.22M-1.95M-1.42M
Cash Flow
Free Cash Flow-1.42M-1.56M-67.84K-1.79M-4.18M-1.19M
Operating Cash Flow-1.42M-1.56M-67.84K-1.79M-3.20M-1.19M
Investing Cash Flow992.79K331.06K0.000.00-980.56K0.00
Financing Cash Flow-715.001.25M0.001.85M3.15M1.24M

BacTech Environmental Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.04
Price Trends
50DMA
0.04
Negative
100DMA
0.05
Negative
200DMA
0.05
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
45.35
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BAC, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.35 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:BAC.

BacTech Environmental Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
49
Neutral
C$51.24M-9.85-14.00%―39.33%-660.48%
45
Neutral
C$39.30M-130.00-6.70%―11.30%97.22%
43
Neutral
C$9.51M-20.0023.13%――44.44%
36
Underperform
C$4.68M-4.05-81.72%―-45.47%55.78%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:BAC
BacTech Environmental
0.04
-0.01
-20.00%
TSE:BLM
BluMetric Environmental
0.93
-0.49
-34.51%
TSE:BQE
BQE Water
66.00
12.11
22.47%
TSE:LUX
Newlox Gold Ventures
0.03
-0.02
-40.00%
TSE:YES
CHAR Technologies
0.26
0.06
30.00%

BacTech Environmental Corporate Events

Business Operations and Strategy
BacTech Targets Peru Tailings in New Bioleaching Expansion
Positive
Sep 3, 2026
BacTech Environmental has launched a new Peru-focused initiative through its wholly owned subsidiary BacTech Verde Peru S.A.C. to identify opportunities for reprocessing historic mine tailings using its BACOX bioleaching technology, targeting gold...
Business Operations and Strategy
BacTech to Test BACOX Bioleaching on Historic Kazakhstan Tailings with Di-As Funding
Positive
Sep 1, 2026
BacTech Environmental has signed a technical consulting and testing agreement with Di-As Company to evaluate the application of its proprietary BACOX bioleaching technology on historic sulphide tailings in the Zyryanovsk district of East Kazakhsta...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2026